EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Genome‐Wide Association Analyses Identify Distinct Genetic Architectures for Extreme Early‐Onset and Late‐Onset T2D

Ben Niu, Ming‐Hui Xia, Jia‐Xin Wu, Fei‐Yan Deng, Hai‐Ying Wu, Shu‐Feng Lei

Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11132-11142

DOI: 10.1111/dom.71302 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Aims Type 2 diabetes (T2D) is a heterogeneous disorder with substantial variation in age at onset (AAO). This study aimed to characterize the distinct genetic architectures and biological mechanisms underlying extreme AAO‐defined T2D subtypes. Materials and Methods Using 74 795 European‐ancestry participants from the UK Biobank, we performed genome‐wide association studies (GWAS) of relatively early‐onset T2D (eoT2D; AAO < 55 years) and late‐onset T2D (loT2D; AAO ≥ 70 years). We investigated subtype‐specific genetic loci, SNP‐based heritability, genetic correlations, Mendelian randomization (MR)‐based relationships, polygenic risk scores (PRS) and phenome‐wide association studies (PheWAS). Single‐cell transcriptomic data from human pancreatic tissues were further used to evaluate cell‐type‐specific expression patterns of candidate genes. Results SNP‐based heritability was substantially higher for eoT2D than loT2D (11.2% vs. 6.4%), with eoT2D displaying distinct genetic loci related to β‐cell function and insulin regulation, including SLC30A8 and IRS1 . By contrast, loT2D showed a comparatively lipid‐related genetic profile, featuring APOE ‐associated signals and expression patterns in immune‐related cell populations. Linkage disequilibrium score regression (LDSC) and MR analyses further underscored this divergence: eoT2D exhibited broader genetic overlap with cardiometabolic traits, whereas loT2D showed stronger relationships with traditional metabolic risk factors. Finally, subtype‐specific PRSs improved risk discrimination beyond conventional covariates, although their clinical utility warrants further evaluation. Conclusions Extreme AAO‐defined T2D subtypes exhibit partially distinct genetic architectures, highlighting AAO as an important dimension of T2D heterogeneity and providing a framework for future age‐stratified genetic risk assessment.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →